LumiraDx Ltd (LMDXF)
0.02
0.00 (0.00%)
USD |
OTCM |
May 17, 15:58
LumiraDx Revenue (Quarterly): 21.00M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 21.00M |
| March 31, 2023 | 22.17M |
| December 31, 2022 | 41.12M |
| September 30, 2022 | 42.22M |
| June 30, 2022 | 44.73M |
| March 31, 2022 | 126.41M |
| Date | Value |
|---|---|
| December 31, 2021 | 118.25M |
| September 30, 2021 | 109.08M |
| June 30, 2021 | 87.22M |
| March 31, 2021 | 106.87M |
| December 31, 2020 | 112.28M |
| September 30, 2020 | 13.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
13.93M
Minimum
Sep 2020
126.41M
Maximum
Mar 2022
70.44M
Average
65.97M
Median
Revenue (Quarterly) Benchmarks
| RadNet Inc | 431.71M |
| DermTech Inc | 3.924M |
| Centogene NV | -- |
| iSpecimen Inc | 2.29M |
| 23andMe Holding Co | 44.75M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -49.74M |
| Total Expenses (Quarterly) | 69.43M |
| EPS Diluted (Quarterly) | -0.15 |
| Gross Profit Margin (Quarterly) | -47.14% |
| Profit Margin (Quarterly) | -236.8% |